With the U.S. House of Representatives slated to consider legislation related to the pandemic this week, NACDS has an important message: constituents view the importance of pharmacy access as a lesson that must be learned from the past three years.
NACDS’ engagement leverages bipartisan momentum for pro-patient, pro-pharmacy PBM reform at state and federal levels.
Ben Pearlman, Esq., has joined the staff of the National Association of Chain Drug Stores (NACDS). He fills the role of director of state government affairs. Most recently, Ben served as senior director of government and public affairs for Shipt, Inc.
NACDS: Floridians, all Americans deserve better than the current “pharmaceutical benefit manipulation”
Texans rank pharmacies as most accessible healthcare destination tested, and support policies that would continue to allow patient choice when it comes to accessing services.
The NACDS-authored column previews the policy outlook for the coming year — and what lies ahead for the future of the industry.
Continues momentum in Tennessee and nationwide to advance patients’ health, convenience, and savings by confronting PBM tactics.
The National Community Pharmacists Association (NCPA), the American Pharmacists Association (APhA), the National Association of Chain Drug Stores (NACDS), the Oklahoma Pharmacists Association (OPA) and American Pharmacies (APRx) issued the following joint press release today.
Last week, NACDS took issue with an op-ed in The Wall Street Journal titled, “In Defense of Pharmacy Benefit Managers (PBMs),” which asserted that “swarms of drug-company lobbyists appear to have united both parties in opposition to [PBMs]” and that PBMs – unreasonably – “are taking the blame for high drug prices.”
On July 8, Florida Governor Ron DeSantis issued an Executive Order “to drive transparency in prescription costs for Floridians.
